Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

An increasing number of preclinical and clinical studies have confirmed a causal relationship between heart and brain diseases. Cardiogenic dementia is a cognitive impairment caused by heart dysfunction and has received increasing research attention.

Dementia 64

Dementia Coronary Artery Disease Quality of Life Myocardial Infarction 64

Cardiovascular Diabetology

NOVEMBER 4, 2024

Aging is influenced by genetic determinants and comorbidities, among which diabetes increases the risk for heart failure with preserved ejection fraction. There is no therapy to prevent heart dysfunction in ag.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Cardiac Function Heart Dysfunction Heart Failure 52

European Journal of Heart Failure

DECEMBER 19, 2024

Patients from higher volume centres more frequently presented in INTERMACS levels 1 and 2, suffered from right heart dysfunction and needed inotropic support. Cumulative follow-up was 10003 patient-years, with a median follow-up of 1.54years (interquartile range 0.523.15). No difference was observed in adjusted 1-year survival.

Outcomes 40

Outcomes Heart Dysfunction Research Article 40

Medical Xpress - Cardiology

FEBRUARY 1, 2024

In a new study published in iScience, Mayo Clinic researchers found that a novel 4D echo imaging method that measures cardiac strain may detect subtle changes in the heart's dysfunction during acute myocarditis, a deadly heart disease.

Heart Disease 105

Heart Disease Heart Dysfunction Research 105

DAIC

APRIL 6, 2024

However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. Researchers tracked outcomes for a median of just under 18 months. SGLT-2 inhibitors were initially approved to treat Type 2 diabetes by lowering blood sugar.

Heart Attack 98

Heart Attack Heart attacks Heart Failure Outpatient 98

DAIC

FEBRUARY 27, 2024

Vincent Cardiovascular Research Institute in Indianapolis, Indiana. The Aria CV Pulmonary Hypertension System is an implantable gas-filled balloon that is introduced percutaneously and functions in the main pulmonary artery to alleviate the excessive workload on the right heart that results in right heart failure.

Pulmonary 110

Pulmonary Hypertension Heart Failure Blood Pressure 110

DAIC

APRIL 6, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24, 24, being held in Atlanta, GA.

Heart Attack 81

Heart Attack Heart attacks Heart Failure Outcomes 81